AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33605864 — intervention group
Group type: COMPARATOR
Intervention: GST T1 null genotype
Number of subjects: 0
Study 33605864 — intervention group
Group type: COMPARATOR
Intervention: IRS-1 TT genotype
Number of subjects: 0
Study 33605864 — intervention group
Group type: COMPARATOR
Intervention: M1-null genotype of GST
Number of subjects: 0
Study 32812824 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese breast cancer survivors
Number of subjects: 105
Study 33200905 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg/die plus tamsulosin 0.4 mg/die combination therapy for 12 weeks
Number of subjects: 50
Study 33318108 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity lifestyle modification programme
Number of subjects: 0
Study 34995334 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-m walkway
Number of subjects: 50
Study 34995334 — intervention group
Group type: COMPARATOR
Intervention: 30-m walkway
Number of subjects: 50
Study 34196924 — intervention group
Group type: EXPERIMENTAL
Intervention: Eversense implantable sensor (EVS)
Number of subjects: 16
Study 34196924 — intervention group
Group type: COMPARATOR
Intervention: Dexcom G5 transcutaneous sensor (DG5)
Number of subjects: 16
Study 33334838 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone on days 1-4
Number of subjects: 280
Study 33334838 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone on day 1 combined with NK1-RA, Palonosetron, and Olanzapine (5 mg)
Number of subjects: 280
Study 35948896 — intervention group
Group type: EXPERIMENTAL
Intervention: ELEVATE intervention (one hour of training four days per week for 12 weeks)
Number of subjects: 0
Study 35948896 — intervention group
Group type: EXPERIMENTAL
Intervention: ELEVATE intervention
Number of subjects: 0
Study 35948896 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group (usual care for six months)
Number of subjects: 0
Study 33771192 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukodepletion filter
Number of subjects: 64
Study 33771192 — intervention group
Group type: COMPARATOR
Intervention: Standard arterial filter (Control)
Number of subjects: 64
Study 33771192 — intervention group
Group type: COMPARATOR
Intervention: Leukodepletion filter and Standard arterial filter (Control)
Number of subjects: 64
Study 32665032 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito-disseminated pyriproxyfen (MD-PPF)
Number of subjects: 0
Study 32665032 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study 34981209 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D echocardiography
Number of subjects: 1441
Study 34981209 — intervention group
Group type: COMPARATOR
Intervention: 2D echocardiography
Number of subjects: 1441
Study 34183717 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume cycling training (60 min per week, low-to-moderate intensity)
Number of subjects: 24
Study 32512498 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatrician-led Newborn Class
Number of subjects: 84
Study 32512498 — intervention group
Group type: COMPARATOR
Intervention: Control (mothers who expressed a desire to attend the class but were discharged before a class was offered)
Number of subjects: 84
Study 34275463 — intervention group
Group type: EXPERIMENTAL
Intervention: Worktivity mobile app (MA)
Number of subjects: 56
Study 34275463 — intervention group
Group type: EXPERIMENTAL
Intervention: Worktivity mobile app plus SSWD (MA+SSWD)
Number of subjects: 56
Study 34275463 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 56
Study 32112448 — intervention group
Group type: EXPERIMENTAL
Intervention: Afforestation
Number of subjects: 1575
Study 32112448 — intervention group
Group type: EXPERIMENTAL
Intervention: Other climate engineering technologies (7 carbon dioxide removal measures and 3 solar radiation management measures)
Number of subjects: 1575
Study 32112448 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived benefits across all technologies
Number of subjects: 1575
Study 32112448 — intervention group
Group type: EXPERIMENTAL
Intervention: Trust in industry/science/government (for all technologies but afforestation)
Number of subjects: 1575
Study 32112448 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived risks and tampering with nature
Number of subjects: 1575
Study 34579067 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation (14 mg zeaxanthin/7 mg lutein)
Number of subjects: 33
Study 34579067 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation
Number of subjects: 33
Study 34579067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32471891 — intervention group
Group type: EXPERIMENTAL
Intervention: CHIPS administration
Number of subjects: 0
Study 36167287 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naltrexone
Number of subjects: 30
Study 36167287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35770558 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibro-acupuncture (VA)
Number of subjects: 58
Study 35770558 — intervention group
Group type: COMPARATOR
Intervention: Manual acupuncture (MA)
Number of subjects: 58
Study 35770558 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (PA)
Number of subjects: 58
Study 33789251 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanins (AC) 320 mg/day in the form of Medox® capsules for 28 days
Number of subjects: 26
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 5082
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily cigarette smoking
Number of subjects: 5082
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Occasional cigarette smoking
Number of subjects: 5082
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily e-cigarette use
Number of subjects: 5082
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Occasional e-cigarette use
Number of subjects: 5082
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily heated tobacco use
Number of subjects: 5082
Study 33882052 — intervention group
Group type: EXPERIMENTAL
Intervention: Occasional heated tobacco use
Number of subjects: 5082
Study 33882052 — intervention group
Group type: COMPARATOR
Intervention: Odds of occasional cigarette smoking
Number of subjects: 5082
Study 33882052 — intervention group
Group type: COMPARATOR
Intervention: Odds of occasional e-cigarette use
Number of subjects: 5082
Study 33882052 — intervention group
Group type: COMPARATOR
Intervention: Odds of daily cigarette smoking
Number of subjects: 5082
Study 33882052 — intervention group
Group type: COMPARATOR
Intervention: Odds of daily heated tobacco use
Number of subjects: 5082
Study 34001451 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT)
Number of subjects: 40
Study 34001451 — intervention group
Group type: COMPARATOR
Intervention: Low central venous pressure (low‐CVP)
Number of subjects: 40
Study 32839957 — intervention group
Group type: EXPERIMENTAL
Intervention: Active continuous theta burst stimulation (cTBS)
Number of subjects: 30
Study 32839957 — intervention group
Group type: COMPARATOR
Intervention: Sham continuous theta burst stimulation (cTBS)
Number of subjects: 30
Study 32839957 — intervention group
Group type: EXPERIMENTAL
Intervention: Distancing
Number of subjects: 30
Study 32839957 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 30
Study 34170096 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathology-confirmed appendicitis (PCA)
Number of subjects: 1189
Study 34170096 — intervention group
Group type: COMPARATOR
Intervention: Delayed diagnosis of appendicitis (DDA)
Number of subjects: 1189
Study 34170096 — intervention group
Group type: COMPARATOR
Intervention: Negative appendectomy (NA)
Number of subjects: 1189
Study 32538011 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Ciliao (BL 32) for 20 min, one hour after delivery (observation group)
Number of subjects: 180
Study 32538011 — intervention group
Group type: COMPARATOR
Intervention: Conditional control group with additional interventions (hot towel application and finger pressing)
Number of subjects: 180
Study 32538011 — intervention group
Group type: COMPARATOR
Intervention: Blank control group with routine nursing plan
Number of subjects: 180
Study 32538011 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Ciliao (BL 32) (observation group)
Number of subjects: 180
Study 32538011 — intervention group
Group type: COMPARATOR
Intervention: Conditional control group with additional interventions
Number of subjects: 180
Study 35012927 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib 80 mg
Number of subjects: 682
Study 35012927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 682
Study 35286913 — intervention group
Group type: EXPERIMENTAL
Intervention: MW032 (120 mg)
Number of subjects: 120
Study 34959872 — intervention group
Group type: EXPERIMENTAL
Intervention: O2-water enriched by injection (110 mg O2·L-1)
Number of subjects: 20
Study 34959872 — intervention group
Group type: EXPERIMENTAL
Intervention: O2-water enriched by electrolysis (110 mg O2·L-1)
Number of subjects: 20
Study 34959872 — intervention group
Group type: COMPARATOR
Intervention: Placebo water (10 mg O2·L-1)
Number of subjects: 20
Study 33794971 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-session Family Talk programme (n = 96)
Number of subjects: 144
Study 33794971 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 48)
Number of subjects: 144
Study 32019559 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic plus exercise intervention (EET)
Number of subjects: 764
Study 32019559 — intervention group
Group type: COMPARATOR
Intervention: Ergonomic plus health promotion intervention (EHP)
Number of subjects: 764
Study 35241130 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electroacupuncture (TEA) on bilateral acupoints of Zusanli (ST36) and Neiguan (PC6) for 4 weeks
Number of subjects: 90
Study 35241130 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous electroacupuncture (sham-TEA)
Number of subjects: 90
Study 35241130 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electroacupuncture (TEA)
Number of subjects: 90
Study 34047704 — intervention group
Group type: EXPERIMENTAL
Intervention: movr app
Number of subjects: 48
Study 34047704 — intervention group
Group type: COMPARATOR
Intervention: waitlist control
Number of subjects: 48
Study 36179677 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsible Behavior with Younger Children (RBYC) intervention
Number of subjects: 160
Study 36179677 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 160
Study 33862286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive, functional, gamified training program using the ArmAble™ device
Number of subjects: 120
Study 33862286 — intervention group
Group type: COMPARATOR
Intervention: Task-based training along with conventional therapy
Number of subjects: 120
Study 32354362 — intervention group
Group type: EXPERIMENTAL
Intervention: Septoplasty (N=102)
Number of subjects: 203
Study 32354362 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical management (N=101)
Number of subjects: 203
Study 36459760 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced forms of prenatal care
Number of subjects: 201
Study 35813320 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel 3D ultrasound imedis9000
Number of subjects: 190
Study 35813320 — intervention group
Group type: COMPARATOR
Intervention: Conventional 2D ultrasound instrument
Number of subjects: 190
Study 32645714 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 50L3
Number of subjects: 24
Study 32645714 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 × 50L3
Number of subjects: 24
Study 32645714 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 × 50L3
Number of subjects: 24
Study 32645714 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated infection with hookworm larvae
Number of subjects: 24
Study 33408197 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous vagal nerve stimulation (tVNS)
Number of subjects: 120
Study 32753637 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Theanine (2.5 mg/kg)
Number of subjects: 5
Study 32753637 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (2.0 mg/kg)
Number of subjects: 5
Study 32753637 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Theanine-caffeine combination
Number of subjects: 5
Study 36150238 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (2.5 mL orally every 8 hours for 1 month)
Number of subjects: 116
Study 36150238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 36162692 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 150
Study 36162692 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 150
Study 36162692 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CAMS and TAU
Number of subjects: 150
Study 33518655 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 100
Study 33518655 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 100
Study 32758689 — intervention group
Group type: EXPERIMENTAL
Intervention: Novaferon
Number of subjects: 89
Study 32758689 — intervention group
Group type: EXPERIMENTAL
Intervention: Novaferon plus Lopinavir/Ritonavir
Number of subjects: 89
Study 32758689 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/Ritonavir
Number of subjects: 89
Study 34379080 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 1561
Study 34379080 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable prediction model
Number of subjects: 1561
Study 35430674 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin treatment with fasting blood glucose (FBG) target of > 3.9 to ≤ 5.6 mmol/L
Number of subjects: 914
Study 35430674 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin treatment with fasting blood glucose (FBG) target of > 3.9 to ≤ 6.1 mmol/L
Number of subjects: 914
Study 35430674 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin treatment with fasting blood glucose (FBG) target of > 3.9 to ≤ 7.0 mmol/L
Number of subjects: 914
Study 35430674 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin treatment
Number of subjects: 914
Study 32224987 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan and magnesium-enriched Mediterranean diet (60 mg of TRY and 60 mg of MG)
Number of subjects: 22
Study 32224987 — intervention group
Group type: COMPARATOR
Intervention: Standard Mediterranean diet
Number of subjects: 22
Study 35970692 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational and motivational messages through a WhatsApp channel
Number of subjects: 501
Study 35970692 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 501
Study 34265658 — intervention group
Group type: EXPERIMENTAL
Intervention: Social distancing primes
Number of subjects: 140
Study 34265658 — intervention group
Group type: COMPARATOR
Intervention: Neutral primes
Number of subjects: 140
Study 33010843 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia
Number of subjects: 503
Study 33010843 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release
Number of subjects: 503
Study 33010843 — intervention group
Group type: EXPERIMENTAL
Intervention: Early structured physiotherapy
Number of subjects: 503
Study 35977283 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviorally informed letters (8 variants)
Number of subjects: 744510
Study 35977283 — intervention group
Group type: COMPARATOR
Intervention: Control group (no letters)
Number of subjects: 744510
Study 35977283 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviorally informed letters (action language)
Number of subjects: 744510
Study 34945237 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Mindfulness-Based Stress Reduction (MBSR) training
Number of subjects: 112
Study 34945237 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated Mindfulness-Based Stress Reduction (MBSR) training
Number of subjects: 112
Study 32542474 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience‐Based Diabetes Self‐Management Education (RB‐DSME)
Number of subjects: 35
Study 34003618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0
Study 34003618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32388492 — intervention group
Group type: EXPERIMENTAL
Intervention: HIE-identified hospital service utilization
Number of subjects: 200
Study 32388492 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods (self-report)
Number of subjects: 200
Study 32388492 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods (self-report + single-system EHR review)
Number of subjects: 200
Study 32886935 — intervention group
Group type: EXPERIMENTAL
Intervention: FCSEMS plus anchoring plastic stent
Number of subjects: 68
Study 32886935 — intervention group
Group type: COMPARATOR
Intervention: FCSEMS alone
Number of subjects: 68
Study 34049443 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine collaborative model of care (TCMCMC) with acupuncture
Number of subjects: 12
Study 32064987 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 155
Study 35799299 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal milk expression (AME) intervention involving technique demonstration and feedback from a lactation consultant, daily independent practice, delivered at weekly visits at 37-40 weeks of pregnancy.
Number of subjects: 45
Study 35799299 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving lactation education handouts.
Number of subjects: 45
Study 35799299 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AME and control groups (feeding any breast milk).
Number of subjects: 45
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels in tumors with high vs low TIL densities
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels in obese vs nonobese patients
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels in men vs women
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels in Blacks vs Whites or Asians
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels in patients with fewer lymph node metastases (N1 vs N2)
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficiency of 25(OH)D
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin and 25(OH)D association with DFS, overall survival, or time to recurrence
Number of subjects: 600
Study 34485815 — intervention group
Group type: EXPERIMENTAL
Intervention: TILs association with prognosis
Number of subjects: 600
Study 35205786 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up by physical examinations + whole-body imaging
Number of subjects: 204
Study 35205786 — intervention group
Group type: COMPARATOR
Intervention: Follow-up by physical examinations only
Number of subjects: 204
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic factors, physical activity, and health status
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Total QoL score
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical health score
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological health score
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Social relationship score
Number of subjects: 2562
Study 33447960 — intervention group
Group type: EXPERIMENTAL
Intervention: Environment score
Number of subjects: 2562
Study 35190388 — intervention group
Group type: EXPERIMENTAL
Intervention: PTED
Number of subjects: 613
Study 35190388 — intervention group
Group type: COMPARATOR
Intervention: Open microdiscectomy
Number of subjects: 613
Study 33879065 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based behavioural activation (iBA) therapy, 12 weekly sessions with online assignments and feedback from trained therapists.
Number of subjects: 390
Study 33879065 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 390
Study 33879065 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based behavioural activation (iBA) therapy
Number of subjects: 390
Study 32196826 — intervention group
Group type: EXPERIMENTAL
Intervention: Altered fractionation (AF) - 1.1 Gy + 2 Gy/d, 5 d/wk, 4.5 weeks, total dose 68 Gy
Number of subjects: 324
Study 32196826 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation (CF) - 2 Gy/d, 5 d/wk, 7 weeks, total dose 68 Gy
Number of subjects: 324
Study 34657303 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2i (dapagliflozin)
Number of subjects: 0
Study 34657303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34733978 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment applied at Baihui (GV20), Yintang (GV29), Shenmen (HT7, bilateral), and Sanyinjiao (SP6, bilateral) 3 times a week for 4 weeks.
Number of subjects: 60
Study 34733978 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture using superficial needles on non-disorder-related acupoints 3 times a week for 4 weeks.
Number of subjects: 60
Study 33706653 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin (SC‐I)
Number of subjects: 19
Study 33706653 — intervention group
Group type: COMPARATOR
Intervention: Intravenous insulin (IV‐I)
Number of subjects: 19
Study 32324850 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based mass testing and treatment (MTaT) performed 3 times per year for 2 years.
Number of subjects: 0